Rankings
▼
Calendar
XERS Q1 2017 Earnings — Xeris Biopharma Holdings, Inc. Revenue & Financial Results | Market Cap Arena
XERS
Xeris Biopharma Holdings, Inc.
$982M
Q1 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$354,000
Gross Profit
$354,000
100.0% margin
Operating Income
-$5M
-1313.3% margin
Net Income
-$5M
-1313.3% margin
EPS (Diluted)
$-2.29
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$158,000
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
$31M
Cash & Equivalents
-$32M
← FY 2017
All Quarters
Q2 2017 →
